Shire Takes Shot At Actavis Over Intuniv ANDA

Law360, New York (May 14, 2010, 4:21 PM EDT) -- Shire LLC has slapped Actavis Inc. and Actavis Elizabeth LLC with a patent infringement suit in a bid to protect the market for attention deficit hyperactivity disorder drug Intuniv, which generated $34.5 million in sales in the first three months of 2010.

The suit was filed Wednesday in the U.S. District Court for the District of Delaware by Shire, Supernus Pharmaceuticals Inc. and three doctors, less than a month after Shire and Supernus brought a complaint against Teva Pharmaceutical Industries Ltd. in the same court over...
To view the full article, register now.